Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 Psychology-Approved Ways to Pick High-Powered Battery Stocks

By Josh Enomoto, InvestorPlace Contributor Oct 7, 2020

Though traditional investing methodologies have their place, everyone will do well to learn how to invest via behavioral finance strategies.

9 New-on-Robinhood Stocks You Can Buy Now

By Josh Enomoto, InvestorPlace Contributor Oct 7, 2020

Here are the latest Robinhood stocks you can buy on the popular trading app, featuring well-rounded selections from several sectors.

Oil Demand Is Nowhere Near Sustainable for Halliburton

By Josh Enomoto, InvestorPlace Contributor Oct 7, 2020

After almost a year of dealing with the coronavirus pandemic, Americans are ready to get back to their normal routines. The only problem for HAL stock is, this demand is nowhere near enough to be considered sustainable for the oil industry.

Niche Software Service JFrog Is Compelling But Possibly Overvalued

By Josh Enomoto, InvestorPlace Contributor Oct 7, 2020

Despite the novel coronavirus, the pandemic hasn’t dampened sentiment for hot IPOs like FROG stock. Still, should you buy now?

Snowflake Doesn’t Need a ‘Safe Space’ for Now

By Josh Enomoto, InvestorPlace Contributor Oct 7, 2020

Thanks to big-time support, SNOW stock has garnered substantial bullish interest. However, the underlying platform – no matter how great it is – risks commoditization later down the road.

Does Sorrento Therapeutics Meet the ‘SAD’ Criteria for Vaccines?

By Josh Enomoto, InvestorPlace Contributor Oct 7, 2020

If you love to gamble, SRNE stock is the right one for you. Few other companies, if any, have pivoted as hard as Sorrento did toward Covid-19. Just be aware of the risks.

7 High-Growth Value Stocks for a Post-Pandemic Future

By Josh Enomoto, InvestorPlace Contributor Oct 6, 2020

Because of the unprecedented Covid-19 crisis, many discounted securities appear to be value stocks. Here are seven names that truly deserve that designation.

Driverless Tech Is Here with the Gores Metropoulos SPAC

By Josh Enomoto, InvestorPlace Contributor Oct 6, 2020

Gores Metropoulos is more than just another SPAC. Via a planned reverse merger with Luminar Technologies, GMHI stock could skyrocket off the underlying autonomous vehicle technology. Just be sure to understand the science before diving in.

Political Ad Debate Is a Temporary Distraction for Facebook

By Josh Enomoto, InvestorPlace Contributor Oct 6, 2020

The vitriolic political race hasn’t done any favors for Facebook stock but don’t forget that this ugly drama will eventually end.

Why Dr. Fauci Holds the Key for Edge Services Provider Fastly

By Josh Enomoto, InvestorPlace Contributor Oct 5, 2020

Not surprisingly, FSLY stock tracks closely with novel coronavirus cases due to the implications of higher data services demand. Because of that, the trajectory of Fastly depends on Dr. Fauci or more specifically, whether Americans will listen to him.